Rankings
▼
Calendar
VTRS (Viatris Inc.) Stock Financials & Earnings | Market Cap Arena
VTRS
Viatris Inc.
Mkt Cap
$17B
Healthcare
·
Drug Manufacturers - Specialty & Generic
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$14.3B
Net Income (TTM)
-$3.5B
EPS (TTM)
-$2.96
Free Cash Flow (TTM)
$1.8B
Gross Margin
35.1%
Op. Margin
-18.6%
Net Margin
-24.6%
FCF Margin
12.7%
P/S Ratio (TTM)
1.2x
P/E Ratio (TTM)
—
YoY Rev Growth
-3.0%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$3.7B
$1.5B
$400M
Q2 23
$3.9B
$1.6B
$369M
Q3 23
$3.9B
$1.7B
$452M
Q4 23
$3.8B
$1.6B
-$455M
Q1 24
$3.7B
$1.5B
$204M
Q2 24
$3.8B
$1.4B
-$240M
Q3 24
$3.8B
$1.5B
$226M
Q4 24
$3.5B
$1.2B
-$180M
Q1 25
$3.3B
$1.2B
-$2.9B
Q2 25
$3.6B
$1.3B
$233M
Q3 25
$3.8B
$1.4B
$252M
Q4 25
$3.7B
$1.1B
-$266M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
1.0x
8.7x
Q2 23
1.1x
8.9x
Q3 23
1.1x
9.1x
Q4 23
1.1x
303.1x
Q1 24
1.1x
—
Q2 24
1.1x
—
Q3 24
1.1x
—
Q4 24
1.1x
—
Q1 25
1.2x
—
Q2 25
1.2x
—
Q3 25
1.2x
—
Q4 25
1.2x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$971M
$889M
Q2 23
$525M
$426M
Q3 23
$835M
$732M
Q4 23
$479M
$279M
Q1 24
$615M
$564M
Q2 24
$379M
$320M
Q3 24
$827M
$741M
Q4 24
$483M
$329M
Q1 25
$536M
$459M
Q2 25
$220M
$166M
Q3 25
$745M
$645M
Q4 25
$816M
$551M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$83M
Q2 23
$99M
Q3 23
$103M
Q4 23
$201M
Q1 24
$51M
Q2 24
$59M
Q3 24
$85M
Q4 24
$153M
Q1 25
$76M
Q2 25
$54M
Q3 25
$100M
Q4 25
$265M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
-11.0%
-4.4%
Q2 23
-4.8%
-0.5%
Q3 23
-3.3%
-0.8%
Q4 23
-1.0%
+5.3%
Q1 24
-1.8%
+3.9%
Q2 24
-3.1%
+13.7%
Q3 24
-4.8%
+1.0%
Q4 24
-8.1%
-13.6%
Q1 25
-11.2%
+77.4%
Q2 25
-5.6%
-17.0%
Q3 25
+0.2%
-0.5%
Q4 25
+5.0%
+7.0%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$43M
1.1%
Q2 23
$39M
1.0%
Q3 23
$43M
1.1%
Q4 23
$56M
1.5%
Q1 24
$47M
1.3%
Q2 24
$35M
0.9%
Q3 24
$32M
0.9%
Q4 24
$32M
0.9%
Q1 25
$55M
1.7%
Q2 25
$37M
1.0%
Q3 25
$36M
1.0%
Q4 25
$49M
1.3%
marketcaparena.com
OpEx Breakdown
R&D
SG&A
Quarter
R&D
SG&A
Q1 23
$183M
$959M
Q2 23
$208M
$1.0B
Q3 23
$211M
$1.1B
Q4 23
$203M
$1.6B
Q1 24
$200M
$1.0B
Q2 24
$204M
$1.0B
Q3 24
$198M
$1.0B
Q4 24
$207M
$1.0B
Q1 25
$222M
$948M
Q2 25
$219M
$929M
Q3 25
$250M
$883M
Q4 25
$275M
$1.0B
marketcaparena.com
Revenue Segments
Brands
Complex GX and Biosimilars
Generics
Quarter
Brands
Complex GX and Biosimilars
Generics
Q1 23
$2.4B
$136M
$1.2B
Q2 23
$2.4B
$139M
$1.3B
Q3 23
$2.5B
$174M
$1.2B
Q1 24
$2.3B
—
$1.3B
Q2 24
$2.4B
—
$1.4B
Q3 24
$2.4B
—
$1.4B
Q1 25
$2.1B
—
$1.1B
Q2 25
$2.3B
—
$1.3B
Q3 25
$2.4B
—
$1.3B
Q4 25
$2.3B
—
$1.3B
marketcaparena.com
Revenue by Geography
Developed Markets Segment
Emerging Markets Segment
Greater China Segment
Japan, Australia and New Zealand Segment
Quarter
Developed Markets Segment
Emerging Markets Segment
Greater China Segment
Japan, Australia and New Zealand Segment
Q1 23
$2.2B
$642M
$565M
$342M
Q2 23
$2.4B
$648M
$532M
$376M
Q3 23
$2.4B
$643M
$548M
$335M
Q4 23
$2.3B
$619M
$515M
$372M
Q1 24
$2.2B
$626M
$544M
$318M
Q2 24
$2.3B
$578M
$539M
$350M
Q3 24
$2.3B
$533M
$562M
$344M
Q4 24
$2.2B
$523M
$523M
$338M
Q1 25
$1.9B
$523M
$556M
$277M
Q2 25
$2.1B
$557M
$589M
$307M
Q3 25
$2.3B
$572M
$615M
$307M
Q4 25
$2.3B
$566M
$573M
$307M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$507M
$174M
$680M
Q2 23
$629M
$177M
$806M
Q3 23
$1.3B
$255M
$1.6B
Q4 23
$992M
$193M
$1.2B
Q1 24
$1.0B
$164M
$1.2B
Q2 24
$917M
$225M
$1.1B
Q3 24
$1.9B
$169M
$2.0B
Q4 24
$735M
$355M
$1.1B
Q1 25
$755M
$247M
$1.0B
Q2 25
$566M
$242M
$809M
Q3 25
$975M
$182M
$1.2B
Q4 25
$1.3B
$106M
$1.5B
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
1.21B
-1.3%
Q2 23
1.20B
-0.2%
Q3 23
1.21B
+0.3%
Q4 23
1.20B
-0.6%
Q1 24
1.21B
+0.8%
Q2 24
1.19B
-1.5%
Q3 24
1.20B
+0.8%
Q4 24
1.19B
-0.6%
Q1 25
1.19B
-0.1%
Q2 25
1.17B
-1.6%
Q3 25
1.16B
-0.7%
Q4 25
1.15B
-1.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
—
—
FY 15
—
—
FY 16
—
—
FY 17
—
—
FY 18
—
—
FY 19
—
—
FY 20
$265K
45K
FY 21
$397K
45K
FY 22
$361K
45K
FY 23
$343K
45K
FY 24
$461K
32K
FY 25
$477K
30K
marketcaparena.com